Jinarc 30 mg, Tabletten - 28 Swissmedic Key 65676004 Registration Holder Otsuka Pharmaceutical (Switzerland) GmbH Name Jinarc 30 mg, Tabletten Date of registration 21.04.2016 Introduction of Sequence 21.04.2016 ATC-Classification Tolvaptan (C03XA01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 05.02. Show package size 28 Index Therapeuticus (Swissmedic) 05.02. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 1288.92 Limitation Yes Limitation text
Deductible 10 % Consumer price 1418.20 Feedback FB Daily cost GTIN 7680656760041 Medication Code Synthetika Pharmacode 6671528 Disponibility
Composition tolvaptanum 30 mg, hydroxypropylcellulosum, lactosum monohydricum 73.826 mg, maydis amylum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, magnesii stearas, E 132 pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Tolvaptanum 30 mg
BAG: Active Agent Dose Tolvaptanum 30 mg
Inactive agents Dose additional_information Cellulosum Microcristallinum E 132 color. Hydroxypropylcellulosum Hydroxypropylcellulosum Substitutum Humile Lactose Monohydrate 73.826 mg Magnesii Stearas Maydis Amylum Pro Compresso
Source Data was imported : 05.01.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
